Expert Opinion on Drug Safety

Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention and treatment

This scoping review (2022) explores the prevalence, risk factors and pathophysiology of hallucinogen persisting perception disorder (HPPD) among different psychedelics. While HPPD is uncommon, current interest in psychedelic research affords the opportunity to characterize HPPD in its frequency, risk and protective factors, key characteristics, and potential treatments.

Published

May 3, 2022

Journal

Expert Opinion on Drug Safety

Authors

Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., McIntyre, R. S., Ho, R.